Nichi-Iko Pharmaceutical Co., Ltd. acted as the seller in this M&A transaction.
The divestment involved assets operating in the Pharmaceuticals sector.
The transaction was announced on 08 Aug 2023 with a reported value of 7360000000.0.
Generated by AI, original source from - Data is in progress
Found it useful? Spread the word.
Latham & Watkins advises Nichi-Iko Pharmaceutical on sale of Sagent Pharmaceuticals and Omega Laboratories to Ellimist Singapore | The Sponsor - The Sponsor
